Hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Here we report a new locus (HFE3) on 7q22 and show that a homozygous nonsense mutation in the gene encoding transferrin receptor-2 (TFR2) is found in people with haemochromatosis that maps to HFE3.
|
10802645 |
2000 |
Hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
The identification of HFE, the principal determinant of adult haemochromatosis (HFE1; OMIM 235200) and TfR2, recently implicated in a rarer form of the inherited disorder (HFE3; OMIM 604250), and the promise of candidate genes for juvenile haemochromatosis (HFE2; OMIM 602390) and neonatal haemochromatosis (OMIM 231100) provide the foundation for important studies into the control mechanism of iron balance in humans.
|
11005792 |
2000 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
TfR2 has a pattern of expression and regulation that is distinct from TfR, and mutations in TfR2 have been recognized as the cause of a non-HFE linked form of hemochromatosis (Camaschella, C., Roetto, A., Cali, A., De Gobbi, M., Garozzo, G., Carella, M., Majorano, N., Totaro, A., and Gasparini, P. (2000) Nat.Genet.25, 14-15).
|
11027676 |
2000 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Recently, a mutation in the gene encoding transferrin receptor-2 (exon 6, nucleotide 750 C --> G; Y250X) was detected by a PCR-restriction fragment length polymorphism (RFLP) method in Sicilians with hemochromatosis.
|
11551099 |
2001 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
A mutation of the transferrin receptor-2 gene (TFR2; exon 6, nt 750 C --> G, replaces TAC with stop signal TAG; Y250X) on Ch7q22 was recently identified in two Sicilian families with HFE mutation-negative hemochromatosis.
|
11358388 |
2001 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Thus, TFR2 mutations are not responsible for hemochromatosis in non-C282Y homozygous patients of our area.
|
11358390 |
2001 |
Hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Recently, two new types of hemochromatosis have been identified: Juvenile hemochromatosis (JH or HFE2), which maps to chromosome 1q21, and an adult form defined as HFE 3, which results from mutations of the TFR 2 gene, located at 7q22.
|
11778658 |
2002 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In particular, the identification of the haemochromatosis gene (HFE) and more recently the transferrin receptor 2 gene (TfR2) together with the specific mutations in these genes which result in hepatic iron overload, has enhanced our understanding of the pathophysiology of haemochromatosis.
|
11886477 |
2002 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
Recently a second transferrin receptor (TFR2) was discovered, and a previously uncharacterized type of hemochromatosis (HH type 3) was identified in humans carrying mutations in the TFR2 gene.
|
12134060 |
2002 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The pathogenetic role of TFR2 in hemochromatosis has been recently further demonstrated through the targeted expression of the Y250X human mutation in mice, which develop sings of iron overload identical to the human disease.
|
12547237 |
2003 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
No individual presented either the mutation at position 845 of the HFE gene or at position 750 of the TFR2 gene, associated with other types of hemochromatosis.
|
12064925 |
2003 |
Hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Taking advantage of the collection of 178 DNA samples selected for increased transferrin saturation (>50% in males and >45% in females) from a previous large scale screening of Italian blood donors, we simultaneously assessed the presence of 14 hemochromatosis-associated molecular defects (11 of HFE and 3 of TFR2) by a reverse hybridization-based strip assay.
|
12681966 |
2003 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Mutations in TfR2 result in hemochromatosis, indicating that this receptor has a unique role in iron metabolism.
|
15317665 |
2004 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The implications of this observation for the understanding of the phenotypic features of haemochromatosis due to mutation of the TFR2 gene are discussed.
|
15084147 |
2004 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Transferrin receptor 2 (TfR2) plays a critical role in iron homeostasis because patients carrying disabling mutations in the TFR2 gene suffer from hemochromatosis.
|
15319276 |
2004 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The genetics of these less common forms was intensively studied between 2000 and 2004, leading to the recognition of haemojuvelin (HJV), hepcidin (HAMP), transferrin receptor 2 (TFR2) and ferroportin-related haemochromatosis, and opening the way for novel hypotheses such as those related to digenic modes of inheritance or the involvement of modifier genes.
|
16132052 |
2005 |
Hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
This suggests that the TfR2 gene is involved in hemochromatosis in Japanese patients.
|
15749661 |
2005 |
Hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Using quantitative RT-PCR, the iron-dependent hepatic expression patterns of HAMP, HJV, and TFR2 were evaluated in human and murine HFE-related hemochromatosis.
|
16103673 |
2005 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Rare defects, including mutations in the transferrin receptor 2 (TFR2) gene, have also been identified in pedigrees affected with "non-HFE hemochromatosis."
|
16234038 |
2005 |
Hemochromatosis
|
0.400 |
Biomarker
|
disease |
LHGDN |
This suggests that the TfR2 gene is involved in hemochromatosis in Japanese patients.
|
15749661 |
2005 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The relationship between the hemochromatosis due to transferrin receptor 2 (TFR2) mutations and hepcidin was unknown.
|
15486069 |
2005 |
Hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Four genes are responsible for the distinct types of non-HFE haemochromatosis: hepcidin and hemojuvelin are the genes involved in type 2 or juvenile haemochromatosis, transferrin receptor 2 is involved in type 3 haemochromatosis, and ferroportin 1 is mutated in type 4, the atypical dominant form of primary iron overload.
|
15737887 |
2005 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
The relationship between the hemochromatosis due to transferrin receptor 2 (TFR2) mutations and hepcidin was unknown.
|
15486069 |
2005 |
Hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
At least three of these entities (HFE hemochromatosis, juvenile hemochromatosis and transferrin receptor 2 hemochromatosis) involve systemic hepcidin deficiency as a key pathogenetic factor.
|
17124037 |
2006 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We conclude that this patient represents another example of hemochromatosis due to mutations of the gene encoding transferrin receptor 2.
|
16424658 |
2006 |